Another study showed that 6-MP also inhibited progression of pulmonary hypertension, where NR4A1 induced bone morphogenic protein LCBMP signaling and decreased inflammation and proliferation in microvascular endothelial cells [125]. Here, NR4A1 is linked to pulmonary hypertension.